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The aim of the present study is to illustrate the effects of swertiamarin (STM), a natural iridoid from 
herbal medicines, on hepatic inﬂammation induced by carbon tetrachloride (CCl4) in rats. Male Sprague 
Dawley rats were exposed to CCl4 with or without STM co-administration for 8 weeks. Our results 
revealed that STM administration (100 and 200 mg/kg b.w.) signiﬁcantly attenuated inﬂammation 
in livers of CCl4-treated rats. STM remarkably reduced the production of interleukin-1β (IL-1β), 
interleukin-6 (IL-6), tumor necrosis factor alpha (TNF-α), macrophage inﬂammatory protein-1a (MIP-
1α), and monocyte chemotactic protein-1 (MCP-1) in liver tissue of CCl4-treated rats. In addition, STM 
treatment downregulated connective tissue growth factor (CTGF) and ser307pIRS-1 expression, which 
was induced by CCl4 exposure. In the process of exploring the anti-inﬂammatory mechanisms of STM 
action, we demonstrated that STM signiﬁcantly inhibited Toll-like receptor 4 (TLR4) and nuclear factor 
kappa B (NF-κB) p65 expression in the liver. In conclusion, these results suggested that the inhibition 
of CCl4-induced inﬂammation by STM was, at least in part, due to its regulation of the TLR4 /NF-κB 
signaling pathway. 
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INTRODUCTION 
Swertiamarin (STM) is a bitter secoiridoid glycoside 
isolated from gentianaceae medicinal plants exerting 
notable hepatoprotective effects (Jaishree, Badami 2010; 
Zhang et al., 2015). In addition, we have previously 
demonstrated that STM could alleviate oxidative stress 
in CCl4-induced hepatotoxicity (Wu et al., 2017). 
However, the underlying molecular mechanisms for its 
hepatoprotective effects have not been fully elucidated. 
There are many molecular events involved in the 
pathogenesis of the liver injury such as oxidative stress, 
inﬂammation, and immune reactions. Among them, 
tissue damage associated with hepatic inﬂammation can 
be mediated by the proinﬂammatory cytokines such as 
inducible nitric oxide synthase, interleukin-1β (IL-1β) 
and tumor necrosis factor alpha (TNF-α) (Ma et al., 
2014). These cytokines can stimulate the Kupffer cells to 
release various inﬂammatory mediators and free radicals 
(Decker 1990). The activation of inﬂammatory cells, 
including Kupﬀer cells, is a crucial step for activating 
hepatic stellate cells. Toll-like receptors (TLRs) have 
been reported to play an essential role in the activation 
of innate immunity (Pestka, Zhou, 2006). In response 
to stimulation of external risk factors, tissues engage 
the innate immune response and up-regulate TLR4 
expression. Activated TLR4 will then stimulate further 
immune responses. Various signaling molecules have 
been shown to regulate the TLR pathway to modulate 
innate immune responses (Fang et al., 2016). The nuclear 
factor kappa B (NF-κB) is one of the most ubiquitous 
transcription factors modulating the immune response to 
infection or stimuli (Tornatore et al., 2012). Expression of 
the proinﬂammatory cytokines is modulated by NF-κB. 
Therefore, NF-κB and TLRs have attracted interest as 
targets for the treatment of inﬂammatory liver damage 
(Shin et al., 2013; Ma et al., 2015). 
The present study aimed to explore the anti-
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inﬂammatory effects and mechanisms of STM on CCl4-
induced liver injury. 
MATERIAL AND METHODS 
Chemicals and reagents 
Swertiamarin (purity>98%, dissolved in 1% 
Tween-20 saline) was provided by Xi’an Jiatian 
Biotechnology Co., Ltd (Xi’an, China). Carbon 
tetrachloride was purchased from Sinopharm Chemical 
Reagent Co., Ltd (Shanghai, China). The levels of aspartate 
aminotransferase (ALT) and alanine aminotransferase 
(AST) were determined by using commercially available 
kits (Jiancheng Institute of Biotechnology, Nanjing, 
China). The ELISA kits for IL-1β, interleukin-6 (IL-6), 
TNF-α, macrophage inflammatory protein-1a (MIP-
1α), and monocyte chemotactic protein-1 (MCP-1) 
were purchased from Neobioscience (Beijing, China). 
Antibodies against connective tissue growth factor 
(CTGF) (Boster, PB0570), TLR4 (Boster, BA1717), NF-
κB p65 (Santa Cruz, sc-1173), ser307pIRS-1 (Boster, 
P00268), GAPDH (Boster, BA2913), and Histone H3 
(Santa Cruz, sc-166574) were used in this study. 
Animals
This study was carried out in strict accordance with 
the guideline of the Council on Animal Care of Academia 
Sinica. The protocol was approved by the Ethical 
Committee on Animal Experimentation of Puai Hospital, 
Tongji Medical College, Huazhong University of Science 
and Technology, China. Adult male Sprague Dawley 
rats weighing 250-280 g were obtained from the Center 
of Experimental Animals of Hubei Province (Wuhan, 
China). All animals were kept under the same laboratory 
conditions of temperature (25 ± 2 °C) and lighting (12:12 
h light: dark cycle) and were given free access to standard 
laboratory chow and tap water. All rats were allowed to 
acclimatize for 1 week before the experiment. 
Experimental design
The animals were randomly assigned to five 
experimental groups (n=12): (1) Control group, rats were 
given 1% Tween-20 saline by gavage once per day for 
8 consecutive weeks with co-administration of vehicle 
(peanut oil, solvent of carbon tetrachloride, 0.3 mL/100 
g, subcutaneously [s. c.] twice a week); (2) STM 200 mg/
kg group, rats were given STM dissolved in 1% Tween-20 
saline (200 mg/kg body weight [b.w.]) by gavage once 
per day for 8 consecutive weeks with co-administration 
of vehicle (peanut oil, solvent of carbon tetrachloride, 0.3 
mL/100 g, s. c. twice a week); (3) CCl4 group, rats were 
given 1% Tween-20 saline by gavage once per day for 8 
consecutive weeks with co-administration of 40% CCl4 
mixed peanut oil solution (0.3 mL/100 g, s. c. twice a 
week); (4) CCl4+STM 10 0 mg/kg group, rats were treated 
with STM dissolved in 1% Tween-20 saline (100 mg/kg 
b.w.) by gavage once per day for 8 consecutive weeks with 
co-administration of 40% CCl4 mixed peanut oil solution 
(0.3 mL/100 g, s. c. twice a week); (5) CCl4+STM 200 
mg/kg group, rats were treated with STM dissolved in 
1% Tween-20 saline (200 mg/kg B.W.) by gavage once 
per day for 8 consecutive weeks with co-administration 
of 40% CCl4 mixed peanut oil solution (0.3 mL/100 g, s. 
c. twice a week). The rats were sacriﬁced at the end of 8 
weeks and 24 h after the last dose of CCl4. Blood and liver 
samples were collected for further analysis. 
Histological examination
Liver samples were derived from the central part of 
the right large lobe of the rats. For hematoxylin and eosin 
staining, the liver tissues were ﬁxed with 10% formalin 
for 24 h, and then washed with tap water, dehydrated, 
and embedded in paraffin. Each slide was subjected to 
histological assessment. 
Measurement of serum aminotransferase 
activities
The activities of ALT and AST in serum were 
determined spectrophotometrically using commercial 
diagnostic kits (Jiancheng Institute of Biotechnology, 
Nanjing, China). 
Assay of IL-1β, IL-6, TNF-α, MIP-1α, and MCP-1 
levels in liver tissue
The IL-1β, IL-6, TNF-α, MIP-1α and MCP-1 levels 
in liver tissue were determined using the respective ELISA 
kits (Neobioscience) according to the instructions of 
manufacturers. 
Western blot analysis
The whole liver lysate was prepared to evaluate the 
expression level of CTGF and TLR4. The nuclear extracts 
of liver tissue were obtained to evaluate the expression 
level of nucleus NF-κB p65 by using a nuclear/cytoplasmic 
isolation kit (Beyotime Institute of Biotechnology, Beijing, 
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China). The protein concentration was determined using 
the bicinchoninic acid assay and samples were stored at 
-80 °C. An equal amount of protein per lane was separated 
by standard 10% SDS-PAGE followed by transfer to 
a polyvinylidene diﬂuoride membrane (Millipore). 
Then the membranes were blocked with Tris-buffered 
saline containing 5% nonfat milk at 4°C. After that, the 
membranes were respectively incubated overnight at 4°C 
in solution containing 0.1% Tween 20, 5% nonfat milk 
and the following primary antibodies: CTGF (1:500), 
TLR4 (1:500), NF-κB p65 (1:400); ser307pIRS-1 (1:400); 
GAPDH (1:20000); Histone H3 (1:1000). After three 
washes in Tris-buffered saline Tween 20, the membranes 
were incubated with the corresponding HRP-conjugated 
secondary antibodies at room temperature. The protein 
bands were quantiﬁed using the Gel-Pro Analyzer software 
(Media Cybernetics, Bethesda, MD). GAPDH or Histone 
H3 was used as an internal control. 
Statistical analysis 
Data were expressed as mean ± S.D. The signiﬁcant 
differences between groups were assessed with SPSS 
version 13.0. The differences between group means 
were calculated by one-way ANOVA with LSD post hoc 
analysis. Difference was considered statistically signiﬁcant 
when p < 0.05, and extremely signiﬁcant when p < 0.01. 
RESULTS AND DISCUSSION 
STM alleviated CCl4-induced liver tissue damage
The hepatic samples of the control and STM 200mg/
kg groups presented normal architecture. However, liver 
tissues from rats intoxicated with CCl4 showed extensive 
histopathological changes, characterized by severe 
hepatocytes degeneration/necrosis, fatty changes, and 
inﬂammatory cell inﬁltration and congestion. The incidence 
and severity of histopathological lesions in CCl4+STM 
groups were less than those in the CCl4 group (Figure 1). 
STM reduced CCl4-elevated serum ALT and AST 
activities
Repeated CCl4 exposure showed elevated activities 
of serum ALT and AST. Treatment with STM obviously 
reduced serum ALT and AST activities as compared with 
the CCl4 group (p < 0.01, Figure 2A-B), which indicated 
the restoration of liver function.
STM reduced the production of pro-inﬂammatory 
cytokines 
The proinflammatory cytokines (IL-1β, IL-6, 
TNF-α, MIP-1α, and MCP-1) proﬁle in liver shown in 
FIGURE 1 - STM alleviated CCl4-induced histology changes in the liver. (A) Control group, (B) STM 200 mg/kg group, (C) CCl4 
group, (D) CCl4+STM 100 mg/kg group, (E) CCl4+STM 200 mg/kg group. Arrows represent the large amount of inﬂammatory 
cell inﬁltration. H&E staining, Magniﬁcation: 200×. 
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Figure 3 showed a signiﬁcant increase in proinﬂammatory 
cytokines in the CCl4-intoxicated rats as compared with 
the control rats. The IL-1β, IL-6, TNF-α, MIP-1α, and 
MCP-1 content in liver tissue of the STM-treated rats was 
signiﬁcantly lower than that in the CCl4 group, suggesting 
the alleviation of liver inﬂammation with STM treatment. 
Note: treatment with STM alone did not have an obvious 
inﬂuence on the cytokine proﬁle. 
STM downregulated CTGF protein expression 
The effect of STM on CTGF protein level in liver 
was determined. Western blotting showed that CTGF 
protein expression in liver tissue was significantly 
increased in the CCl4 group as compared with the control 
group (p < 0.05). STM treatment down-regulated CTGF 
protein level notably in liver tissue as compared with the 
CCl4 group (Figure 4). 
STM regulated protein expression in the TLR4 
signaling pathway 
The effect of STM on the TLR4 signaling pathway 
activation was examined. We assessed the activation of 
the signaling molecules, including TLR4 and NF-κB 
p65. Western blotting showed that cytoplasmic TLR4 and 
nuclear NF-κB p65 protein expression in liver tissue was 
signiﬁcantly induced in the CCl4 group as compared with 
the control group (p < 0.01). STM treatment markedly 
inhibited the CCl4-induced increase of TLR4 and NF-κB 
p65 protein expression in liver tissue. The results are 
shown in Figure 4. 
STM downregulated pIRS-1 
The expression level of phosphorylated ser-307 
IRS-1 in a liver sample was determined with western 
blotting. The ser307pIRS-1 expression in liver tissue was 
signiﬁcantly elevated in the CCl4 group compared with the 
control group (p < 0.05). STM treatment (200 mg/kg b.w.) 
downregulated the ser307pIRS-1 level notably in liver in 
comparison with the CCl4 group (Figure 5). 
In this article we showed that STM, a natural iridoid 
compound, was instrumental in attenuating liver injury in 
rats induced by a repeated CCl4 intoxication. The doses 
of STM (100 and 200 mg/kg b.w.) were based on the 
previously published articles on experimental liver injury 
(Jaishree, Badami 2010; Zhang et al., 2015; Chen et al., 
2017). In the present study, a repeated CCl4 exposure 
resulted in a signiﬁcant increase in serum ALT and AST 
levels, biomarkers of liver injury. In addition, severe liver 
lesion and inﬂammatory response were also triggered by 
CCl4. All of the aforementioned pathological changes were 
signiﬁcantly improved with STM treatment. Additionally, 
cytoplasmic TLR4 and nuclear accumulation of the NF-κB 
p65 in the livers of CCl4-intoxicated rats were signiﬁcantly 
decreased by the administration of STM, suggesting a 
possible mechanism of action. 
Liver inﬂammation is a common response to 
various types of chronic liver injury. In the initial stages of 
inﬂammation, the hepatocytes, Kupffer cells, platelets, and 
leukocytes are activated to produce ROS and inﬂammatory 
mediators such as platelet-derived growth factor (PDGF), 
transforming growth factor-β (TGF-β), CTGF, and 
TNF-α. These factors probably act as paracrine mediators 
FIGURE 2 - STM improved CCl4-induced changes in hepatic functional markers. (A) ALT activity; (B) AST activity. Data are 
represented as means ± S.D. for 7-12 animals per group. * p < 0.05 versus control, ** p < 0.01 versus control; # p < 0.05 versus CCl4, 
## p < 0.01 versus CCl4 by one-way ANOVA and LSD post hoc test.
Swertiamarin attenuates carbon tetrachloride (CCl4)-induced liver injury and inﬂammation in rats by regulating the TLR4 signaling pathway
Braz. J. Pharm. Sci. 2018;54(4):e17449 Page 5 / 9
FIGURE 3 - STM inhibited the hepatic production of IL-1β, IL-6, TNF-α, MIP-1α, and MCP-1. The contents of IL-1β, IL-6, TNF-α, 
MIP-1α, and MCP-1 in liver were signiﬁcantly increased following 8 weeks of chronic CCl4 exposure compared with the controls. 
STM (100 and 200 mg/kg) treatment reduced the production of IL-1β, IL-6, TNF-α, MIP-1α, and MCP-1 notably compared with the 
CCl4 group. Data are represented as means ± S.D. for 7-12 animals per group. * p < 0.05 versus control, ** p < 0.01 versus control; 
# p < 0.05 versus CCl4, ## p < 0.01 versus CCl4 by one-way ANOVA and LSD post hoc test.
to activate quiescent HSCs that are localized in the 
perisinusoidal space, resulting in an abnormal quantity and 
composition of extracellular matrix, which in turn leads 
to hepatitis, liver ﬁbrosis, and cirrhosis (Wu, Zern, 2000). 
Thus, it is important to suppress hepatic inﬂammation in 
the early stages of liver ﬁbrosis.
Cytokines/chemokines may promote inﬂammatory 
development via a wide variety of cascade events. 
IL-6 release can relate to acute phase of liver lesions 
associated with inﬂammation and may induce the release 
of other proinﬂammatory cytokines (Liang et al., 2014). 
Considerable evidence suggests that IL-1β and TNF-α 
contribute to the pathogenesis of liver inﬂammatory 
diseases by activating the NF-κB signaling pathway 
(Muriel, 2009). In addition, it has been reported that acute 
hepatotoxicity with CCl4 leads to NF-κB activation and 
very high expression of IL-1β, IL-6, and TNF-α (Reyes-
Gordillo et al., 2007). In addition, chronic CCl4 treatment 
could also induce a severe degree of liver inﬂammation 
and necrosis evidenced by an increase in the mRNA levels 
of various proinﬂammatory cytokines and chemokines 
such as TNF-α, IL-1β, MIP-1α, MIP-2, and MCP-1 
(Mukhopadhyay et al., 2014). These cytokines are also 
valuable indicators of hepatic inﬂammation. In our study, 
STM treatment signiﬁcantly inhibited these cytokines (IL-
1β, IL-6, TNF-α, MIP-1α, and MCP-1) induced by CCl4 
that were consistent with relieved liver injury. 
Hepatic fibrogenesis depends on preexistent and 
continuous liver injury, in part due to inflammatory 
cell infiltration (Gao, Jeong, Tian, 2008). CTGF is a 
matricellular protein that participates in critical processes 
including differentiation, development, tumor growth, and 
Tao W., Qianrui Z., Hongping S.
Braz. J. Pharm. Sci. 2018;54(4):e17449Page 6 / 9
FIGURE 4 - STM repressed the protein expression of CTGF, TLR4 and NF-κB p65 in the liver. The CTGF protein level of rats in 
CCl4+STM 100 mg/kg and CCl4+STM 200 mg/kg groups were downregulated signiﬁcantly compared with the CCl4 group. The 
protein expression of TLR4 and NF-κB p65 of rats in CCl4+STM 100 mg/kg and CCl4+STM 200 mg/kg groups were signiﬁcantly 
lower than that in the CCl4 group. Data are represented as means ± S.D for 3-4 animals per group. 
* p < 0.05 versus control, ** p < 
0.01 versus control; # p < 0.05 versus CCl4, ## p < 0.01 versus CCl4 by one-way ANOVA and LSD post hoc test.
FIGURE 5 - STM downregulated pIRS-1. The expression level of the ser307pIRS-1 in liver tissue was signiﬁcantly elevated in 
the CCl4 group as compared with the control group (p < 0.05). STM (200 mg/kg b.w.) treatment downregulated the ser307pIRS-1 
level notably in liver as compared with the CCl4 group (p < 0.01). Data are represented as means ± S.D. for 3-4 animals per group. 
* p < 0.05 versus control, ** p < 0.01 versus control; # p < 0.05 versus CCl4, ## p < 0.01 versus CCl4 by one-way ANOVA and LSD 
post hoc test.
wound healing (Brigstock, 1999). CTGF has been shown 
to be a pivotal mediator of hepatic ﬁbrogenesis (Tong et 
al., 2009). The expression of CTGF is obviously elevated 
in livers from rodents subjected to bile duct ligation or 
exposure to CCl4 (Williams et al., 2000; Sedlaczek et 
al., 2001). Our results showed that STM signiﬁcantly 
downregulated CTGF expression, which was induced by 
CCl4, contributing to the restrictions on ﬁbrogenesis and 
inﬂammatory reaction in the liver. 
CCl 4 in toxica t ion  can  ac t iva te  numerous 
intracellular signaling pathways (such as MAPK, 
TGF-β1), which may converge on NF-κB (Ma et al., 
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2011; Wang et al., 2013). Activation of NF-κB in 
liver cells results in the recruitment of inflammatory 
cytokines/mediators, thus inducing fibrosis (Luedde, 
Schwabe, 2011). In addition, many studies from 
mouse and human had indicated that TLRs are central 
mediators of the inﬂammatory response and crucial 
links between inﬂammation and ﬁbrosis in chronic liver 
diseases (Schwabe, Seki, Brenner, 2006; Berzsenyi 
et al., 2011). TLR4 exhibits a fundamental role in 
managing innate immunity activation and regulates 
the recruitment of cytokines that are necessary for the 
progression of inﬂammation (Wei et al., 2015). TLR4 
is also strongly associated with the progression of 
liver ﬁbrosis (Aoyama, Paik, Seki, 2010). Speciﬁcally, 
modulation of TGF-β signaling by a TLR4-MyD88–NF-
κB axis provides a novel link between proinﬂammatory 
and proﬁbrogenic signals (Seki et al., 2007). The 
present ﬁndings revealed that high levels of NF-κB and 
TLR4 in liver cells of CCl4-treated rats reﬂected liver 
impairments that are associated with inflammation. 
Interestingly, these two proinflammatory genes were 
downregulated by administration of STM. As a result, we 
postulated that the molecular mechanism against CCl4-
triggered hepatotoxication is linked to STM-mediated 
inactivation of the TLR4/NF-κB pathway, in which the 
benefit contributes to synergistic roles of attenuating 
immunotoxicity and inflammatory response in CCl4-
lesioned liver tissue, further improving liver functions.
CCl4 intoxication could induce diffuse hepatosteatosis 
in rats (Cetinkaya et al., 2013). Excess free fatty acids 
are activators of various protein kinases that lead to Ser 
307 phosphorylation of IRS-1, a hallmark of insulin 
resistance (Patel et al., 2016). The phosphorylation of 
IRS-1 has been reported to play a role in an in vitro model 
of obesity-induced inﬂammation (Lopez-Vazquez et al., 
2017). Here we tested the inﬂuence of swertiamarin on the 
ser307pIRS-1 expression in CCl4-induced hepatotoxicity. 
The increased expression of the ser307pIRS-1 in 
CCl4-intoxicated rats was notably down-regulated by 
swertiamarin treatment (200 mg/kg b.w.), suggesting a 
novel mechanism.
In summary, our findings demonstrate that STM 
may be an alternative detoxifying medication due to its 
potential hepatoprotective and anti-inﬂammatory effects. 
Although underlying mechanisms have been discussed 
(Figure 6), further studies need to be explored. 
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